ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 169 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $80,028 | -52.6% | 16,200 | +3.2% | 0.00% | – |
Q3 2022 | $169,000 | -1.2% | 15,700 | -16.4% | 0.00% | – |
Q1 2022 | $171,000 | -54.3% | 18,771 | +31.2% | 0.00% | -100.0% |
Q2 2021 | $374,000 | +36.0% | 14,310 | +83.5% | 0.00% | +100.0% |
Q1 2021 | $275,000 | +12.2% | 7,800 | +20.0% | 0.00% | 0.0% |
Q3 2020 | $245,000 | -31.8% | 6,500 | -22.6% | 0.00% | -50.0% |
Q2 2020 | $359,000 | – | 8,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $46,213,000 | 13.24% |
Wildcat Capital Management, LLC | 1,716,370 | $44,111,000 | 5.71% |
TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $481,009,000 | 4.77% |
Copernicus Capital Management, LLC | 15,000 | $386,000 | 4.67% |
Coastal Bridge Advisors, LLC | 301,240 | $7,742,000 | 1.79% |
Lombard Odier Asset Management (Switzerland) SA | 914,416 | $23,500,000 | 1.46% |
Casdin Capital, LLC | 2,100,000 | $53,970,000 | 1.34% |
Pier Capital, LLC | 450,182 | $11,570,000 | 1.20% |
Ghost Tree Capital, LLC | 150,000 | $3,855,000 | 1.13% |
Sessa Capital IM, L.P. | 750,000 | $19,275,000 | 0.95% |